IMMUNOVX
Live / Applied — Statement of use — processing complete, to examiner (as of 02 Mar 2026)
What this means for you
Not registered yet, but its 18 Jul 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98089376
- Mark type
- Stylized text
- Filed
- 18 Jul 2023
- Published for opposition
- 11 Feb 2025
- Attorney of record
- Sean P. McConnell
Goods and services
- Class 042 — Scientific and technological services: Clinical research in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Research and development and consultation related thereto in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific research; Scientific research consulting; Basic and clinical research in the field of respiratory science and medicine; Biochemical research and development; Consulting services for others in the field of design, planning, and implementation project management of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Medical and scientific research in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research and development; Product research and development; Providing information about medical and scientific research; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Scientific research in the nature of conducting clinical trials for others in the field of pharmaceutical, biologic, biotechnology, vaccine, infectious disease treatment, and adjuvant research and development
Owner
- Banerjee, Dalfoni, G., Bethlehem, PA, US
- Banerjee, Dalfoni, G., Conshohocken, PA, US
Prosecution history
- 02 Mar 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Aug 2025 — USE AMENDMENT FILED
- 28 Feb 2026 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 25 Aug 2025 — TEAS STATEMENT OF USE RECEIVED
- 08 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 11 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Feb 2025 — PUBLISHED FOR OPPOSITION
- 05 Feb 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Jan 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Jan 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 20 Jan 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Jan 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 20 Jan 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 17 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED